Journal article

Venetoclax plus obinutuzumab therapy for front-line treatment of chronic lymphocytic leukaemia

JF Seymour

Lancet Oncology | ELSEVIER SCIENCE INC | Published : 2020

DOI: 10.1016/S1470-2045(20)30484-8

University of Melbourne Researchers

John Seymour Author

Citation metrics

3Web of Science

Keywords

Science & Technology

Life Sciences & Biomedicine

32 Biomedical and Clinical Sciences

3211 Oncology and Carcinogenesis